GASPS Study: General Anaesthesia vs Spinal anaesthesia: Patient outcomes and Success in Outpatient primary total knee and hip Arthroplasty
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 600
- 试验地点
- 2
- 主要终点
- Successful same-day discharge, defined as: • The patient is discharged from the hospital on the same day as the surgery and, • the patient is not readmitted within 48 hours of discharge.
研究概览
简要总结
To determine whether the use of General anaesthesia (GA) compared to Spinal anaesthesia (SA) is associated with a higher frequency of successful same-day discharge in patients undergoing outpatient TKA and THA Successful same-day discharge is defined as: • Discharge on the day of surgery, and • No readmission within 48 hours of discharge.
入排标准
- 年龄范围
- 18 years 至 65+ years(18-64 Years, 65+ Years)
- 接受健康志愿者
- 否
入选标准
- •The participant has given their written consent to participate in the trial.
- •Planned for primary TKA or THA.
- •Adults aged 18 to 80 years at time of written consent.
- •ASA (American Society of Anesthesiologists) classification 1 or 2, or 3 without significant functional impairment.
- •Scheduled start of surgery before 13:
- •Ability to communicate in Swedish, ensuring understanding of informed consent and follow-up procedures.
排除标准
- •Indication for surgery other than degenerative or inflammatory joint diseases (e.g. fracture).
- •Women of childbearing potential (i.e., those who are fertile, following menarche and until becoming post-menopausal, unless permanently sterile) a. Who are not willing to use a highly effective method of contraception judged by the investigator, from the time of signing the informed consent, OR b. Who has a positive pregnancy test at enrolment
- •Individual unwilling or unable to receive either spinal or general anaesthesia
- •Participation or recent participation in a clinical trial with an investigational medicinal product within 30 days.
- •Previous participation in this trial.
- •Body mass index (BMI) > 35 kg/m.
- •Preoperative opioid use exceeding 20 mg oral morphine equivalents daily.
- •Haemoglobin <120 g/L (sample no older than 3 months).
- •Known bleeding disorders, including coagulopathies.
- •Known allergies to investigational anaesthetic drugs (e.g., bupivacaine, remifentanil, or propofol).
- •Neurological conditions with persistent motor or sensory deficits.
- •Localised infections at the spinal injection site.
- •Determined by the surgical or anaesthesia team to be unsuitable for trial participation and/or outpatient surgery.
研究组 & 干预措施
REMIFENTANIL , PROPOFOL
干预措施: REMIFENTANIL (Drug)
REMIFENTANIL , PROPOFOL
干预措施: PROPOFOL (Drug)
BUPIVACAINE, SUFENTANIL , FENTANYL
干预措施: BUPIVACAINE (Drug)
BUPIVACAINE, SUFENTANIL , FENTANYL
干预措施: SUFENTANIL (Drug)
BUPIVACAINE, SUFENTANIL , FENTANYL
干预措施: FENTANYL (Drug)
结局指标
主要结局
Successful same-day discharge, defined as: • The patient is discharged from the hospital on the same day as the surgery and, • the patient is not readmitted within 48 hours of discharge.
Successful same-day discharge, defined as: • The patient is discharged from the hospital on the same day as the surgery and, • the patient is not readmitted within 48 hours of discharge.
次要结局
- Time from start of anaesthesia to start of surgery (Phase II).
- Time from start of surgery to discharge from the postoperative recovery unit (Phase II).
- Time from start of surgery to fulfilment of indicators for end phase III (intermediate recovery) as outlined in the protocol (table 4).
- Time from start of surgery to discharge from hospital (Phase III).
- Time from start of surgery to first successful mobilisation, assessed by the ability to walk with tolerable pain and ascend/descend stairs if applicable.
- Use of analgesics (opioids converted to Oral morphine equivalents (OME)).
- Patient-reported quality of recovery using the Swedish Version of Quality of Recovery - 15 (QoR-15) from postoperative day (POD) 1 to POD 35.
- Pain levels measured using the Numeric Rating Scale (NRS) during the recovery period (postoperative until discharge to ward)
- Knee injury and Osteoarthritis Outcome Score (KOOS) at baseline, 4 weeks, 6 months 12 months.
- Hip disability and Osteoarthritis Outcome Score (HOOS), at baseline, 4 weeks, 6 months 12 months.
- Use of analgesics (opioids converted to Oral morphine equivalents (OME)). Daily postoperative day 1-14, weekly day 15-35
- Incidence, severity and frequency of adverse events (AEs) and serious adverse events (SAEs), until postoperative day 3.
- Incidence and frequency of predefined adverse outcomes. (Table 1), until postoperative day 3.
- Units of blood transfusion, until discharge from hospital
- Key themes from patient-reported experiences of anaesthesia and postoperative care, gathered through semi-structured interviews conducted 14–60 days post-surgery.
- Incremental cost-effectiveness ratios (ICERs) comparing costs and quality-adjusted life years (QALYs) gained between GA and SA.
研究者
Kristofer Nilsson
Scientific
Region Oerebro Laen
